lobbying_activities: 1657724

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1657724	241ff137-0be4-4dd6-bf3b-0f6c408dd87a	Q1	RED+BLUE STRATEGIES	400693064	EXPRESS SCRIPTS INC.	2015	first_quarter	MMM	Policies and regulations focused on Medicare Part C and Part D with a focus on coverage of prescription medications, formulary design and access to specialty drugs. Policies focused on ensuring affordable access to Biosimilar medications for Medicare and Medicaid beneficiaries as well as those in the private market. Policies focused on ending prescription drug abuse in the Medicare Part D program. Issues related to the Medicare Call letter related to preferred pharmacy networks in Medicare Part D. ACA- related regulations impacting Federal and State Based Marketplaces'' coverage of prescription medications. Issues related to cost of and access to specialty medications and their impact on consumers and purchasers.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2015-04-09T12:05:04.293000-04:00